Non-Invasive Cancer Testing

The IvyGene test is a blood test that uses advanced DNA sequencing methods to detect the DNA methylation pattern of circulating tumor DNA (ctDNA) in blood samples in order to both confirm the presence of cancer and give quantifiable data about cancer presence.

Unlike many genetic tests that investigate DNA mutations to determine the propensity or possibility of developing cancer over time, the IvyGene test identifies DNA methylation patterns consistent with disease presence and gives quantifiable data about cancer presence at the time of testing.

Learn More


UpComing: Conferences

The building blocks of IvyGene were published in Nature Materials! Learn more about DNA Methylation and how this technology is being used in revolutionary new ways. Visit the link to learn more: www.nature.com/nmat

Stop by and visit our booth at our upcoming conferences.

  • Age Management Medicine Group (AMMG)
    November 2-5, 2017 – Tucson, Arizona
  • A4M
    December 14-16, 2017 – Las Vegas, NV
  • Molecular Med Tri-Con
    February 11-16, 2018 – San Francisco, CA
  • AACR
    April 14-18, 2018 – Chicago, Illinois

Learn More

Connect with Us

 



Find provider
(coming soon)

Information Request